Cerity Partners’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.84M Buy
133,827
+4,576
+4% +$91.5K ﹤0.01% 1287
2025
Q4
$2.11M Sell
129,251
-4,103
-3% -$62K ﹤0.01% 1354
2025
Q3
$1.56M Sell
133,354
-7,418
-5% -$96.7K ﹤0.01% 1401
2025
Q2
$1.63M Buy
140,772
+114,407
+434% +$1.04M ﹤0.01% 1306
2025
Q1
$230K Sell
26,365
-3,663
-12% -$46.2K ﹤0.01% 2149
2024
Q4
$451K Sell
30,028
-6,339
-17% -$100K ﹤0.01% 1822
2024
Q3
$821K Buy
36,367
+10,815
+42% +$224K ﹤0.01% 1501
2024
Q2
$497K Buy
25,552
+555
+2% +$14.5K ﹤0.01% 1548
2024
Q1
$938K Buy
24,997
+10,500
+72% +$461K ﹤0.01% 1306
2023
Q4
$811K Buy
+14,497
New +$631K ﹤0.01% 1062
2023
Q2
Sell
-14,183
Closed -$790K 1949
2023
Q1
$790K Sell
14,183
-869
-6% -$40.6K ﹤0.01% 1083
2022
Q4
$548K Sell
15,052
-133
-0.9% -$4.35K ﹤0.01% 901
2022
Q3
$432K Sell
15,185
-1,636
-10% -$62.3K 0.01% 768
2022
Q2
$761K Buy
16,821
+338
+2% +$17.5K 0.01% 615
2022
Q1
$1.25M Buy
16,483
+14,491
+727% +$1.27M 0.02% 408
2021
Q4
$296K Buy
1,992
+416
+26% +$63.7K ﹤0.01% 773
2021
Q3
$229K Buy
1,576
+127
+9% +$21.8K 0.01% 622
2021
Q2
$284K Buy
1,449
+202
+16% +$36.6K 0.01% 598
2021
Q1
$226K Buy
+1,247
New +$215K 0.01% 627

Other funds holding TXG